Healthcare Wire Texas
SEE OTHER BRANDS

Exploring the health and wellness news of Texas

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on April 15, 2025

Centre Technologies Appoints CFO to Support Strategic Growth Across Texas and Oklahoma

Centre Technologies Appoints CFO to Support Strategic Growth Across Texas and Oklahoma

Chris McMahan joins the rapidly growing MSP, Centre Technologies, as CFO. This addition continues to boost Centre's already prominent growth across TX and OK. HOUSTON, TX, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Centre Technologies, a …

Stephen Levi Carter Named a 2025 Top 50 Black Professional & Entrepreneur of Texas by d-mars.com

Stephen Levi Carter Named a 2025 Top 50 Black Professional & Entrepreneur of Texas by d-mars.com

d-mars.com has proudly named Stephen Levi Carter, MBA, PMP, as one of its Top 50 Black Professionals …

Cubhub Roars Into IDD Services with TaskMaster Pro Acquisition

Cubhub Roars Into IDD Services with TaskMaster Pro Acquisition

Cubhub strengthens its Medicaid-based platform and enters IDD space with the acquisition of TaskMaster Pro, expanding its home care tech footprint. FORT WORTH, TX, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Cubhub, a leading provider of …

Strengthen Continuity Plans Now, Industry Insiders Warn

Strengthen Continuity Plans Now, Industry Insiders Warn

As economic uncertainty grows, businesses must prepare for disruptions to cash flow and operations. HOUSTON, TX, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Leading invoice funding company Charter Capital says now is the time to shore up …

EXTRAORDINARY NURSES RECOGNIZED AT Nobis Rehabilitation Partners

EXTRAORDINARY NURSES RECOGNIZED AT Nobis Rehabilitation Partners

Nobis Rehabilitation Partners Launches The DAISY Award for Extraordinary Nurses ® Throughout Its Rehabilitation Hospitals ALLEN, TX, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Nurses at Nobis Rehabilitation Partners managed hospitals will soon …

GEO Receives Second Patent for GEO-Desis, GEO’s Next Generation Lapidus Arthrodesis System

GEO Receives Second Patent for GEO-Desis, GEO’s Next Generation Lapidus Arthrodesis System

RICHARDSON, TX, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Gramercy Extremity Orthopedics (GEO), a developer of RFID technology, medical devices, and software solutions in the healthcare industry announced that the United States Patent and …

Dovetail Software Leads Vendor Satisfaction and User Experience in HR Service Delivery for Fourth Straight Year

Dovetail Software Leads Vendor Satisfaction and User Experience in HR Service Delivery for Fourth Straight Year

Consistent excellence highlights Dovetail’s ongoing commitment to innovation and customer satisfaction AUSTIN, TX, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Dovetail Software, a leader in HR Service Delivery solutions, is proud to announce it …

BlueCloudX Launches Revolutionary GDPR Connectivity Business Model for Healthcare and Clinical Research

BlueCloudX Launches Revolutionary GDPR Connectivity Business Model for Healthcare and Clinical Research

Empowering Global Stakeholders with Secure, Compliant, and Scalable Data-Sharing Infrastructure AUSTIN, TX, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- BlueCloudX, a global leader in healthcare and clinical research connectivity, has officially …

Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) who are apolipoprotein E ε4 (ApoE ε4*) non-carriers or …

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan1) in …

Fatima Rifai Expands Functional Diet Supplement Business Amid Lebanon’s Economic Crisis

Fatima Rifai Expands Functional Diet Supplement Business Amid Lebanon’s Economic Crisis

Photo Courtesy of Diet By Tam BEIRUT, Lebanon, April 15, 2025 (GLOBE NEWSWIRE) -- Diet by Tam, a health and wellness company based in Beirut, has announced the expansion of its functional supplement range with the introduction of five new products. The …

Theratechnologies Provides Update on Sale Process

Theratechnologies Provides Update on Sale Process

MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that following careful consideration of the current …

Theratechnologies fait le point sur le processus de vente

Theratechnologies fait le point sur le processus de vente

MONTRÉAL, 15 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui qu’après un examen attentif des circonstances …

Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies

Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies

BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today announced that the first patient in China has been dosed in the …

Ascension Seton to Take Full Ownership of Cedar Park Medical Center, Strengthening Patient-Centered Care

Ascension Seton to Take Full Ownership of Cedar Park Medical Center, Strengthening Patient-Centered Care

CEDAR PARK, Texas, April 15, 2025 (GLOBE NEWSWIRE) -- Ascension Seton is deepening its commitment to patient-centered care in Central Texas by acquiring full ownership of Cedar Park Medical Center. This transition marks a significant step in Ascension …

Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer

Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of Leonardo Viana Nicacio, M …

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that on April 14, 2025, non- …

Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025

Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025

Reports expansion of CompuFlo® Epidural System across additional  pain management clinics and ambulatory surgery centers following  Medicare price assignment in multiple U.S. states ROSELAND, N.J., April 15, 2025 (GLOBE NEWSWIRE) --  Milestone Scientific …

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the Company’s Cell Pouch Bio-hybrid Organ in clinical …

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

Merger creates a Nasdaq-listed, clinical-stage biopharmaceutical company – Tvardi Therapeutics – developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi shares to begin trading under the symbol “TVRD” on April 16, 2025 Post- …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service